Has there been any discussion about DXB being sold (to big pharma)? I haven't seen that come up in materials or company presentations I have reviewed to date so I thought I might ask the question whether that is (also) part of the strategy.
DXB Chart, page-372
-
- There are more pages in this discussion • 780 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.010(2.04%) |
Mkt cap ! $264.1M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 49.5¢ | 46.5¢ | $2.386M | 4.999M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 161364 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 78070 | 5 |
View Market Depth
| Last trade - 15.00pm 15/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |